CX3CL1/Fractalkine Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-76467
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human, Mouse
Applications
ELISA, Immunoprecipitation, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Format
BSA Free
Concentration
1 mg/ml
Product Summary for CX3CL1/Fractalkine Antibody - BSA Free
Immunogen
Antibody was raised against a peptide corresponding to 18 amino acids near the amino terminus of human CX3CL1. The immunogen is located within amino acids 20 - 70 of CX3CL1. Amino Acid Squence: CSKMTSKIPVALLIHYQQN
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for CX3CL1/Fractalkine Antibody - BSA Free
Western Blot: CX3CL1/Fractalkine AntibodyBSA Free [NBP1-76467]
Western Blot: CX3CL1/Fractalkine Antibody [NBP1-76467] - C2C12 cell lysate with CX3CL1 antibody at (A) 0.5, (B) 1 and (C) 2 mg/ml.Applications for CX3CL1/Fractalkine Antibody - BSA Free
Application
Recommended Usage
ELISA
1:100-1:2000
Western Blot
0.5-2 ug/ml
Application Notes
CX3CL1 is ofen observed migrating at 80 - 100 kDa in SDS-PAGE, presumably due to post-translational modification.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Peptide affinity purified
Formulation
PBS
Format
BSA Free
Preservative
0.02% Sodium Azide
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: CX3CL1/Fractalkine
Additional CX3CL1/Fractalkine Products
Product Documents for CX3CL1/Fractalkine Antibody - BSA Free
Product Specific Notices for CX3CL1/Fractalkine Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...